BSEResult6d ago · 14 Aug 2026, 04:35 pm

Results for the Quarter ended 30 June 2026

Medico Intercontinental Ltd · 539938

✦ AI SummaryResults

Medico Intercontinental Ltd has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, along with a limited review report by its statutory auditors, V. Goswami & Co. The company's board of directors has approved the results and has scheduled an annual general meeting for September 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Medico Intercontinental Ltd - 539938 - Results - Quarter Ended 30 June 2026

Attachments (1)

📄

4eed7768-a314-4b68-b410-80eb38f95ad8.pdf

pdf

Download →
View document text
= = INTERCONTINENTAL LTD. CIN: L24100GJ1984PLC111413 Reg. Office: 1-5th Floor, Aditraj Arcade, Nr Karma Shreshtha Tower, 100 Ft Rd, Satellite, Ahmedabad - 380015. Date: 14t August, 2026 Listing Compliances, Listing Compliances, BSE Limited, CSE - India, P.J. Towers, 7, Lyons Range, Dalhousie Fort, Mumbai - 400001. Kolk- a70t00a01 . Scrip Code: 539938; Scrip Id: MIL Subject: Outcome of Board Meeting and Compliances of Regulation 30, 33 and 42 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. Dear Sir/Ma’am, Pursuant to provisions of Regulation 30, 33 and 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e, August 14, 2026, inter alia, considered and approved: 1. Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended on June 30, 2026 along with Limited review report issued by M/s. V Goswami & Co, Statutory Auditors of the Company. 2. Notice of Annual General Meeting, Board’s report along with Annexures thereon. 3. The Annual General Meeting of the Company will be held on Wednesday, 30 September, 2026 at 02:00 P.M. through Video Conferencing (VC) / Other Audio Visual Means (OAVM). 4. The cut-off date for the purpose of the Annual General Meeting is 23+ September, 2026. 5. The Register of members and share transfer books will remain closed from 24t September, 2026 to 30t September, 2026 (both days inclusive) for the purpose of the AGM. 6. The e-voting will commence from Sunday, 27% September, 2026 at 9:00 AM. and shall conclude on Tuesday, 29™ September, 2026 at 5:00 P.M. 7. Mr. Yash Mehta, Practicing Company Secretary has been appointed as Scrutinizer for the purpose of e-voting at Annual General Meeting. Further, please find enclosed “Standalone and Consolidated unaudited Financial Results along with Limited Review Report” for the quarter ended on June 30, 2026 as Annexure 1 and same is also available on the website of the Company viz. www.medicointercontinental.com The Board Meeting of the Company commenced at 01:00 PM and concluded at 04:20 PM. This is for your information and records. Thanking You, FORMEDICO INTERCONTI TAL LIMITED CONTIA, AuMEDABRD) Samir D Shah Managing Director (DIN: 03350268) Godown Address: 12 & 19/1a, Madhav Estate, Near IBP Petrol pump, Forest Section-1, Aslali, Ahmedabad-382427. Ph. No.: 079-26742739, Fax No. 079-26742740. Email ID: mail@medicointercontinental.com Website: www.medicointercontinental.com RBI UCN NO. :- 897783 V. GO SWAMI 8 Co. C&AG REG NO. :- WR4659 WoiA CHARTERED ACCOUNTANTS | cMoSrM E . s:-i smGJm-r0v1a-o0r1e4r9i6e5s8 B-1006, Titanium Square, Opp.Thaltej Metro, S.G. Highway, Thaltej, Ahmeabad-380059. M :+91 94287 33430, +91 97247 28711 | E-mail : thegoswami@gmail.com | www.goswami.in Independent Auditor’s Review Report on Standalone Unaudited Quarterly Financial Results of the Company Pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) TO THE BOARD OF DIRECTORS OF MEDICO INTERCONTINENTAL LIMITED We have reviewed the accompanying Statements of Standalone Unaudited Financial Results of MEDICO INTERCONTINENTAL LIMITED (“the company”), for the quarter ended June 30, 2026 (“the Statement”), being submitted by the Company pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, including relevant circulars issued by the SEBI from time to time. This Statement, which is the responsibility of the Company's Management and approved by the Company's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 “Interim Financial Reporting" ("Ind AS 34"), prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India. Our responsibility is to express a conclusion on the Statement based on our review. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410 ‘Review of Interim Financial Information Performed by the Independent Auditor of the Entity ', issued by the Institute of Chartered Accountants of India (ICAl). A review of interim financial information consists of making inquiries, primarily of the Company's personnel responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under section 143(10) of the Companies Act, 2013 and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. RBI UCN NO. :- 897783 V. GO SWAMI 8 C O. C&AG REG NO. :- WR4659 ™woi1A CHARTERED ACCOUNTANTS | cMoSrM E . s:-a nmGJi-r0v1s-o0r1s4t9i6z5s8 B-1006, Titanium Square, Opp.Thaltej Metro, S.G. Highway, Thaltej, Ahmeabad-380059. M : +91 94287 33430, +91 97247 28711 | E-mail : thegoswami@gmail.com | www.goswami.in Based on our review conducted as stated in paragraph 3 above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the aforesaid Indian Accounting Standard and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, including the manner in which it is to be disclosed, or that it contains any material misstatement. For, V. GOSWAMI & CO, Chartered Accountants (FRN:0128769W) QQ/L/—/ vv@; (Partner) Mem No:119809 Place: -Ahmedabad Date: - 14/08/2026 UDIN: 26119809YXXYDH9130 MEDICO INTERCONTINENTAL LIMITED CIN: 1241006/1984PLC111413 Regd. Off: 1-5TH FLOOR, ADIT RAJ ARCADE NR KARMA, SHRESHTHA TOWER, 100 FT RD, SATELLITE,Ahmedabad GJ 380015 IN Tel No. 079-26742739 E-mail:- mail@medicointercontinental.com Website: www.medicointercontinental.com Statement of Standalone Unaudited Financial Results for the Quarter ended June 30, 2026 (Rs in Lakhs) Quarter ended Year ended STANDALONE STANDALONE 3Months ended | Preceding 3 Months | Corresponding3 | _ Previous year ended ended months ended in previous vear on sr. Particulars 30-06-2026 31-03-2026 30-06-2025 31032026 NoJ| Unaudited Audited Unaudited Audited Revenues 1 Revenue from Operations 1433.29 1582.34] 1346.68] 5446.08] 2 Other Income 50.73] 72.98 24.19) 234.54 3 [Total Revenue (A) 1524.02] 1655.31] 1370.86] 5680.62) 7 [Expenses (2)_[Cost of materials consumed 0.000} 0.00 0.000 0.00] (b) [Purchases of stockin-trade 1189.11 1306.79) 947.94] 4486.22| (c) |Changes in inventories of finished goods and stock-in-trade 87.64] 3818 12851 82.69) (d) [Employee benefits expense 5635 66.18 5088 246.03 () [Finance costs 47.83) 39.87 2352 166.83) (7)_|Depreciation and amortisation expense 11.25) 15.83 17.56 69.35) (¢)_|Other expenses 5055 11538 108.76 317.86 Total Expenses (B) 1442.73] 1582.23] 1297.18] 5368.98) 5 [Profit/{Loss) before exceptional items & tax (1-4) 81.29] 73.08) 73.68 311.64) 6 |Exceptional items 0.00 0.00 0.00 0.00) 7_|Profit/{Loss) for the period from operations before tax (5+6) 81.29) 73.08 73.68| 311.64] 8 [Tax expense 20.53] 30.67 18.08] 93.28) () [Current Tax 2197 31.22 1971 95.07| (b) _|Deffered Tax 144 -0.55. 163 -1.79) 9 |Profit/(Loss) for the period from continuing operations (7-8) 60.76] 42.41] 55.60) 218.359) 10 [Profit/{loss) for the period from discontinued operations 000 0.00| 0.00 0.00) 11 [Tax expense of discontinued operations 000 0.00) 000 0.00) 12 [Profit/{loss) for the period from Discontinued operations (after tax] 000 0.00 [Showing first 8,000 characters — download PDF for full document]